{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:05:44Z","timestamp":1782536744103,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13760-020-01477-1","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T05:02:26Z","timestamp":1598504546000},"page":"949-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-6613","authenticated-orcid":false,"given":"Tamer","family":"Yazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Olgun Yazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Cihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"9","key":"1477_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00415-015-7881-6","volume":"262","author":"KJ Peall","year":"2015","unstructured":"Peall KJ, Robertson NP (2015) Biomarkers in Alzheimer\u2019s disease: understanding disease trajectory and therapeutic targets. J Neurol 262(9):2195\u20132197. https:\/\/doi.org\/10.1007\/s00415-015-7881-6","journal-title":"J Neurol"},{"issue":"2","key":"1477_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11845-018-1858-2","volume":"188","author":"A Daly","year":"2019","unstructured":"Daly A, Walsh D (2019) Dementia-a majorpublichealth problem: the role of in-patientpsychiatricfacilities. Iran J Med Sci 188(2):641\u2013647. https:\/\/doi.org\/10.1007\/s11845-018-1858-2","journal-title":"Iran J Med Sci"},{"issue":"8","key":"1477_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7150\/ijms.12742","volume":"12","author":"IU Song","year":"2015","unstructured":"Song IU, Chung SW, Kim YD et al (2015) Relationship between the hs-CRP as non-specific biomarker and Alzheimer\u2019s disease according to aging process. Int J Med Sci. 12(8):613\u2013617. https:\/\/doi.org\/10.7150\/ijms.12742","journal-title":"Int J Med Sci."},{"issue":"9","key":"1477_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.2174\/1389203718666170911145321","volume":"19","author":"A Alexiou","year":"2018","unstructured":"Alexiou A, Soursou G, Yarla NS et al (2018) Proteins commonly linked to autism spectrum disorder and Alzheimer\u2019s disease. Curr Protein Pept Sci 19(9):876\u2013880","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"1477_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10072-018-3293-6","volume":"39","author":"T Yazar","year":"2018","unstructured":"Yazar T, Yazar HO, Demir EY et al (2018) Assessment of the mental health of carers according to the stage of patients with diagnosis of Alzheimer-type dementia. Neurol Sci 39(5):903\u2013908. https:\/\/doi.org\/10.1007\/s10072-018-3293-6","journal-title":"Neurol Sci"},{"issue":"2","key":"1477_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/ene.12761","volume":"23","author":"Y Jung","year":"2016","unstructured":"Jung Y, Whitwell JL, Duffy JR et al (2016) Regional \u03b2-amyloid burden does not correlate with cognitive or language deficits in Alzheimer\u2019s disease presenting as aphasia. Eur J Neurol 23(2):313\u2013319. https:\/\/doi.org\/10.1111\/ene.12761","journal-title":"Eur J Neurol"},{"issue":"1","key":"1477_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","volume":"19","author":"PC Tiwari","year":"2017","unstructured":"Tiwari PC, Pal R (2017) The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialog Clin Neurosci 19(1):71\u201380","journal-title":"Dialog Clin Neurosci"},{"key":"1477_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fncel.2018.00242","volume":"12","author":"R Timmerman","year":"2018","unstructured":"Timmerman R, Burm SM, Bajramovic JJ (2018) An overview of in vitro methods to study microglia. Front Cell Neurosci 12:242. https:\/\/doi.org\/10.3389\/fncel.2018.00242","journal-title":"Front Cell Neurosci"},{"key":"1477_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuint.2018.07.003","volume":"120","author":"R Niranjan","year":"2018","unstructured":"Niranjan R (2018) Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration. Neurochem Int 120:13\u201320. https:\/\/doi.org\/10.1016\/j.neuint.2018.07.003","journal-title":"Neurochem Int"},{"key":"1477_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jocn.2019.08.032","volume":"70","author":"HO Yazar","year":"2019","unstructured":"Yazar HO, Yazar T, Cihan M (2019) A preliminary data: evaluation of serum Galectin-3 levels in patients with idiopathic Parkinson\u2019s disease. J Clin Neurosci 70:164\u2013168. https:\/\/doi.org\/10.1016\/j.jocn.2019.08.032","journal-title":"J Clin Neurosci"},{"issue":"8","key":"1477_CR11","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/ijms19082195","volume":"19","author":"ZS Wu","year":"2018","unstructured":"Wu ZS, Lo JJ, Wu SH et al (2018) Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model. Int J Mol Sci 19(8):2195. https:\/\/doi.org\/10.3390\/ijms19082195","journal-title":"Int J Mol Sci"},{"key":"1477_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4103\/1673-5374.255359","volume":"14","author":"W Gomes-Leal","year":"2019","unstructured":"Gomes-Leal W (2019) Why microglia kill neurons after neural disorders? The friendly fire hypothesis. Neural Regen Res 14:1499\u20131502","journal-title":"Neural Regen Res"},{"key":"1477_CR13","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","volume":"8","author":"STT Schetters","year":"2018","unstructured":"Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ et al (2018) Neuroinflammation: microglia and T Cells Get Ready to Tango. Front Immunol 8:1905. https:\/\/doi.org\/10.3389\/fimmu.2017.01905","journal-title":"Front Immunol"},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-014-0156-0","volume":"2","author":"A Boza-Serrano","year":"2014","unstructured":"Boza-Serrano A, Reyes JF, Rey NL et al (2014) The role of Galectin-3 in \u03b1-synuclein-induced microglial activation. Acta Neuropathol Commun 2:156. https:\/\/doi.org\/10.1186\/s40478-014-0156-0","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1477_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WS (2004) Microglia and neuroinflammation: a pathological perspective. J Neuroinflamm 1(1):14. https:\/\/doi.org\/10.1186\/1742-2094-1-14","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1477_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41598-018-19699-y","volume":"8","author":"A Boza-Serrano","year":"2018","unstructured":"Boza-Serrano A, Yang Y, Paulus A et al (2018) Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer\u2019s disease mouse model 5xFAD. Sci Rep 8(1):1550. https:\/\/doi.org\/10.1038\/s41598-018-19699-y","journal-title":"Sci Rep"},{"key":"1477_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-374947-5.00034-1","author":"NG Bazan","year":"2012","unstructured":"Bazan NG, Halabi A, Ertel M, Petasis NA (2012) Neuroinflammation. Basic Neurochem. https:\/\/doi.org\/10.1016\/b978-0-12-374947-5.00034-1","journal-title":"Basic Neurochem"},{"key":"1477_CR18","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:S10\u2013S17","journal-title":"Nat Med"},{"issue":"9","key":"1477_CR19","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","volume":"10","author":"MA Burguillos","year":"2015","unstructured":"Burguillos MA, Svensson M, Schulte T et al (2015) Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep 10(9):1626\u20131638. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.012","journal-title":"Cell Rep"},{"key":"1477_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/0028-3886.177600","volume":"64","author":"M Tripathi","year":"2016","unstructured":"Tripathi M, Dixit A (2016) Chandra PS (2016) Galectin-3, an important yet unexplored molecule in drug resistant epilepsy. Neurol India 64:237\u2013238","journal-title":"Neurol India"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.acthis.2012.11.010","volume":"115","author":"T Shin","year":"2013","unstructured":"Shin T (2013) The pleiotropic effects of galectin-3 in neuroinflammation: a review. Acta Histochem 115:407\u2013411. https:\/\/doi.org\/10.1016\/j.acthis.2012.11.010","journal-title":"Acta Histochem"},{"issue":"1","key":"1477_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","volume":"272","author":"RA de Boer","year":"2012","unstructured":"de Boer RA, van Veldhuisen DJ, Gansevoort RT et al (2012) The fibrosis marker\u00a0galectin-3\u00a0and outcome in the general population. J Intern Med 272(1):55\u201364. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02476.x","journal-title":"J Intern Med"},{"issue":"30","key":"1477_CR23","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1523\/jneurosci.1498-12.2012","volume":"32","author":"M Lalancette-H\u00e9bert","year":"2012","unstructured":"Lalancette-H\u00e9bert M, Swarup V, Beaulieu JM et al (2012) Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci 32(30):10383\u201310395. https:\/\/doi.org\/10.1523\/jneurosci.1498-12.2012","journal-title":"J Neurosci"},{"issue":"2","key":"1477_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","volume":"182","author":"HR Jiang","year":"2009","unstructured":"Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, Fukada SY et al (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182(2):1167\u20131173","journal-title":"J Immunol"},{"issue":"1","key":"1477_CR25","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY et al (2019) Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun 10(1):3473. https:\/\/doi.org\/10.1038\/s41467-019-11441-0","journal-title":"Nat Commun"},{"issue":"Suppl 2","key":"1477_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ Di Sabato","year":"2016","unstructured":"Di Sabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139(Suppl 2):136\u2013153. https:\/\/doi.org\/10.1111\/jnc.13607","journal-title":"J Neurochem"},{"key":"1477_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2990.2012.01306.x","volume":"39","author":"DM Norden","year":"2013","unstructured":"Norden DM, Godbout JP (2013) Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39:19\u201334","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"17587","DOI":"10.1523\/jneurosci.3241-13.2013","volume":"33","author":"M Schwartz","year":"2013","unstructured":"Schwartz M, Kipnis J, Rivest S et al (2013) How do immune cells support and shape the brain in health, disease, and aging? J Neurosci 33:17587\u201317596. https:\/\/doi.org\/10.1523\/jneurosci.3241-13.2013","journal-title":"J Neurosci"},{"issue":"7","key":"1477_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"issue":"2","key":"1477_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4274\/tnf.galenos.2019.85698","volume":"25","author":"T Yazar","year":"2019","unstructured":"Yazar T, Yazar HO (2019) Assessment of serum uric acid levels according to sex and stage for patients with alzheimer-type dementia. Turk J Neurol 25(2):76\u201381. https:\/\/doi.org\/10.4274\/tnf.galenos.2019.85698","journal-title":"Turk J Neurol"},{"issue":"3","key":"1477_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11845-018-01957-7","volume":"188","author":"H Olgun Yazar","year":"2019","unstructured":"Olgun Yazar H, Yazar T (2019) Prevalence of sarcopenia in patients with geriatric depression diagnosis. Iran J Med Sci 188(3):931\u2013938. https:\/\/doi.org\/10.1007\/s11845-018-01957-7","journal-title":"Iran J Med Sci"},{"key":"1477_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","volume":"182","author":"HR Jiang","year":"2009","unstructured":"Jiang HR, Al Rasebi Z, Mensah-Brown E et al (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182:1167\u20131173. https:\/\/doi.org\/10.4049\/jimmunol.182.2.1167","journal-title":"J Immunol"},{"key":"1477_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2012.07.058","volume":"1475","author":"A Pajoohesh-Ganji","year":"2012","unstructured":"Pajoohesh-Ganji A, Knoblach SM, Faden AI et al (2012) Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res 1475:96\u2013105. https:\/\/doi.org\/10.1016\/j.brainres.2012.07.058","journal-title":"Brain Res"},{"issue":"2","key":"1477_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ene.13223","volume":"24","author":"K Brockmann","year":"2017","unstructured":"Brockmann K, Schulte C, Schneiderhan-Marra N et al (2017) Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson\u2019s disease. Eur J Neurol 24(2):427. https:\/\/doi.org\/10.1111\/ene.13223","journal-title":"Eur J Neurol"},{"issue":"2","key":"1477_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.13496","volume":"25","author":"A Venkatraman","year":"2018","unstructured":"Venkatraman A, Hardas S, Patel N et al (2018) Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases. Eur J Neurol 25(2):238\u2013246. https:\/\/doi.org\/10.1111\/ene.13496","journal-title":"Eur J Neurol"},{"issue":"12","key":"1477_CR36","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/ene.13440","volume":"24","author":"P Arora","year":"2017","unstructured":"Arora P, Agarwal Z, Venkatraman A et al (2017) Galectin-3 and risk of ischaemic stroke: reasons for geographic and racial differences in stroke cohort. Eur J Neurol 24(12):1464\u20131470. https:\/\/doi.org\/10.1111\/ene.13440","journal-title":"Eur J Neurol"},{"issue":"2","key":"1477_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/brainsci8020030","volume":"8","author":"H Nishikawa","year":"2018","unstructured":"Nishikawa H, Suzuki H (2018) Possible Role of Inflammation and galectin-3 in brain injury after subarachnoid hemorrhage. Brain Sci 8(2):30. https:\/\/doi.org\/10.3390\/brainsci8020030","journal-title":"Brain Sci"},{"issue":"2","key":"1477_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q, Zheng S, Soh A, Zheng Y et al (2018) Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int J Mol Med 41(2):599\u2013614. https:\/\/doi.org\/10.3892\/ijmm.2017.3311","journal-title":"Int J Mol Med"},{"issue":"2","key":"1477_CR39","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.3390\/ijms19020379","volume":"19","author":"S Sciacchitano","year":"2018","unstructured":"Sciacchitano S, Lavra L, Morgante A, Ulivieri A, Magi F, De Francesco G et al (2018) Galectin- 3: one molecule for an alphabet of diseases, from A to Z. Int J Mol Sci 19(2):E379. https:\/\/doi.org\/10.3390\/ijms19020379","journal-title":"Int J Mol Sci"},{"key":"1477_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fnins.2018.00430","volume":"12","author":"GM Ashraf","year":"2018","unstructured":"Ashraf GM, Baeesa SS (2018) Investigation of Gal-3 expression pattern in serum and cerebrospinal fluid of patients suffering from neurodegenerative disorders. Front Neurosci 12:430. https:\/\/doi.org\/10.3389\/fnins.2018.00430","journal-title":"Front Neurosci"},{"issue":"4","key":"1477_CR41","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s13311-015-0385-3","volume":"12","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff RM, Schafer D, Vincent A et al (2015) Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics 12(4):896\u2013909. https:\/\/doi.org\/10.1007\/s13311-015-0385-3","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1477_CR42","doi-asserted-by":"publisher","first-page":"e0148792","DOI":"10.1371\/journal.pone.0148792","volume":"11","author":"Z Ma","year":"2016","unstructured":"Ma Z, Han Q, Wang X, Ai Z et al (2016) Galectin-3 inhibition is associated with neuropathic pain attenuation after peripheral nerve injury. PLoS ONE 11(2):e0148792. https:\/\/doi.org\/10.1371\/journal.pone.0148792","journal-title":"PLoS ONE"},{"issue":"8","key":"1477_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/1533317513495107","volume":"30","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang S, Lin F et al (2015) Elevated galectin-3 levels in the serum of patients with Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen 30(8):729\u2013732. https:\/\/doi.org\/10.1177\/1533317513495107","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"3","key":"1477_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/1352458516655217","volume":"23","author":"H Nishihara","year":"2017","unstructured":"Nishihara H, Shimizu F, Kitagawa T et al (2017) Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis. Mult Scler J 23(3):382\u2013394. https:\/\/doi.org\/10.1177\/1352458516655217","journal-title":"Mult Scler J"},{"issue":"2","key":"1477_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-01","volume":"138","author":"A Boza-Serrano","year":"2019","unstructured":"Boza-Serrano A, Ruiz R, Sanchez-Varo R et al (2019) Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease. Acta Neuropathol 138(2):251\u2013273. https:\/\/doi.org\/10.1007\/s00401-01","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01477-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T23:55:02Z","timestamp":1630022102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01477-1","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"To perform the study, permission was granted by Ordu University Education and Research Hospital ethics committee (Decision number: 2019\/14). All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical aspect of the research and consent to participate"}}]}}